
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Spatial and molecular profiling of the mononuclear phagocyte network in Classic Hodgkin lymphoma
Benjamin Stewart, Martin Fergie, Matthew D. Young, et al.
Blood (2023)
Closed Access | Times Cited: 26
Benjamin Stewart, Martin Fergie, Matthew D. Young, et al.
Blood (2023)
Closed Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling
Stefan Alig, Mohammad Shahrokh Esfahani, Andrea Garofalo, et al.
Nature (2023) Vol. 625, Iss. 7996, pp. 778-787
Open Access | Times Cited: 50
Stefan Alig, Mohammad Shahrokh Esfahani, Andrea Garofalo, et al.
Nature (2023) Vol. 625, Iss. 7996, pp. 778-787
Open Access | Times Cited: 50
Identification of a core transcriptional program driving the human renal mesenchymal-to-epithelial transition
John-Poul Ng-Blichfeldt, Benjamin Stewart, Menna R. Clatworthy, et al.
Developmental Cell (2024) Vol. 59, Iss. 5, pp. 595-612.e8
Open Access | Times Cited: 7
John-Poul Ng-Blichfeldt, Benjamin Stewart, Menna R. Clatworthy, et al.
Developmental Cell (2024) Vol. 59, Iss. 5, pp. 595-612.e8
Open Access | Times Cited: 7
Immune checkpoint inhibitors in advanced and relapsed/refractory Hodgkin lymphoma: current applications and future prospects
Charles Milrod, Ari Pelcovits, Thomas Ollila
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Charles Milrod, Ari Pelcovits, Thomas Ollila
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses
Xiufen Chen, Jovian Yu, Girish Venkataraman, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 3, pp. 296-307
Closed Access | Times Cited: 4
Xiufen Chen, Jovian Yu, Girish Venkataraman, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 3, pp. 296-307
Closed Access | Times Cited: 4
The biology of classical Hodgkin lymphoma
Samuel Kosydar, Stephen M. Ansell
Seminars in Hematology (2024) Vol. 61, Iss. 4, pp. 212-220
Closed Access | Times Cited: 4
Samuel Kosydar, Stephen M. Ansell
Seminars in Hematology (2024) Vol. 61, Iss. 4, pp. 212-220
Closed Access | Times Cited: 4
A Case of Hodgkin Lymphoma in a Gaucher Disease Patient: Distinguishing Gaucher and Pseudo‐Gaucher Cells
Natalia Scaramellini, Marta Canzi, Elena Cassinerio, et al.
American Journal of Hematology (2025)
Closed Access
Natalia Scaramellini, Marta Canzi, Elena Cassinerio, et al.
American Journal of Hematology (2025)
Closed Access
Computational pathology identifies a low B-cell content in the tumour microenvironment as a predictor of adverse outcome in patients with classic Hodgkin lymphoma treated with ABVD
Antonio Santisteban‐Espejo, C. de la Fuente, Alipio Mangas, et al.
Journal of Clinical Pathology (2025), pp. jcp-209848
Closed Access
Antonio Santisteban‐Espejo, C. de la Fuente, Alipio Mangas, et al.
Journal of Clinical Pathology (2025), pp. jcp-209848
Closed Access
The regulatory role of PI3Kδ inhibitor idelalisib in TAM polarization and immune modulation in NHL: A potential surgical immunotherapy target
Cia‐Hin Lau, Mingxing Zhong, Yuting Chen, et al.
Asian Journal of Surgery (2025)
Open Access
Cia‐Hin Lau, Mingxing Zhong, Yuting Chen, et al.
Asian Journal of Surgery (2025)
Open Access
A Novel NIR-dependent IDO-inhibiting Ethosomes Treatment Melanoma through PTT/PDT/Immunotherapy synergy
Changzhen Sun, Qingqing He, Yang Xun, et al.
Colloids and Surfaces B Biointerfaces (2025) Vol. 251, pp. 114565-114565
Closed Access
Changzhen Sun, Qingqing He, Yang Xun, et al.
Colloids and Surfaces B Biointerfaces (2025) Vol. 251, pp. 114565-114565
Closed Access
DNA methylation-regulated HLA-C expression modulates immune responses and metabolic alterations to influence prognosis in mesothelioma
Huilin Zhang, Liang Yu, Yue Guo, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 5
Open Access
Huilin Zhang, Liang Yu, Yue Guo, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 5
Open Access
Optimizing Treatment for Relapsed/Refractory Classic Hodgkin Lymphoma in the Era of Immunotherapy
Michael P. Randall, Michael A. Spinner
Cancers (2023) Vol. 15, Iss. 18, pp. 4509-4509
Open Access | Times Cited: 9
Michael P. Randall, Michael A. Spinner
Cancers (2023) Vol. 15, Iss. 18, pp. 4509-4509
Open Access | Times Cited: 9
Mapping the Spatial Dynamics of the CD4+ T Cell Spectrum in Classical Hodgkin Lymphoma
Victoria Menéndez, José L Solórzano, Mónica García-Cosío, et al.
Modern Pathology (2024) Vol. 37, Iss. 9, pp. 100551-100551
Closed Access | Times Cited: 3
Victoria Menéndez, José L Solórzano, Mónica García-Cosío, et al.
Modern Pathology (2024) Vol. 37, Iss. 9, pp. 100551-100551
Closed Access | Times Cited: 3
Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment
Rebecca Masel, Megan E. Roche, Ubaldo Martinez‐Outschoorn
Best Practice & Research Clinical Haematology (2023) Vol. 36, Iss. 4, pp. 101514-101514
Closed Access | Times Cited: 8
Rebecca Masel, Megan E. Roche, Ubaldo Martinez‐Outschoorn
Best Practice & Research Clinical Haematology (2023) Vol. 36, Iss. 4, pp. 101514-101514
Closed Access | Times Cited: 8
Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma
José Luis Solórzano, Victoria Menéndez, Edwin R. Parra, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
José Luis Solórzano, Victoria Menéndez, Edwin R. Parra, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Advances in Hodgkin lymphoma research
Ralf Küppers
Trends in Molecular Medicine (2024)
Open Access | Times Cited: 1
Ralf Küppers
Trends in Molecular Medicine (2024)
Open Access | Times Cited: 1
Recent revelations and future directions using single-cell technologies in chronic lymphocytic leukemia
Blaž Oder, Anastasia Chatzidimitriou, Anton W. Langerak, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Blaž Oder, Anastasia Chatzidimitriou, Anton W. Langerak, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Increasing microenvironment complexity in HL
Paola Chabay
Blood (2023) Vol. 141, Iss. 19, pp. 2290-2291
Open Access | Times Cited: 2
Paola Chabay
Blood (2023) Vol. 141, Iss. 19, pp. 2290-2291
Open Access | Times Cited: 2
Location, location, location: mapping the lymphoma tumor microenvironment using spatial transcriptomics
Keir Pickard, Emily Stephenson, Alex Mitchell, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Keir Pickard, Emily Stephenson, Alex Mitchell, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma
Arina Martynchyk, Rakin Chowdhury, Eliza A. Hawkes, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5217-5217
Open Access | Times Cited: 2
Arina Martynchyk, Rakin Chowdhury, Eliza A. Hawkes, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5217-5217
Open Access | Times Cited: 2
Emerging immunotherapies in the Hodgkin Lymphoma Armamentarium
Michael A. Spinner, Ranjana H. Advani
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 3, pp. 263-275
Open Access
Michael A. Spinner, Ranjana H. Advani
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 3, pp. 263-275
Open Access
Antibody–Drug Conjugate Made of Zoledronic Acid and the Anti-CD30 Brentuximab–Vedotin Exert Anti-Lymphoma and Immunostimulating Effects
F. Morelli, Serena Matis, Roberto Benelli, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 862-862
Open Access
F. Morelli, Serena Matis, Roberto Benelli, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 862-862
Open Access
The Role of New Research Parameters of the BC 6800 Plus Analyzer in the Differential Diagnosis of Lymphoid Neoplasms
Sara Sacchetti, Daniela Ferrante, Luca Giacomini, et al.
(2024)
Open Access
Sara Sacchetti, Daniela Ferrante, Luca Giacomini, et al.
(2024)
Open Access
Single‐cell RNA sequencing of pediatric Hodgkin lymphoma to study the inhibition of T cell subtypes
Jurrian K. de Kanter, Alexander S. Steemers, Daniel Montiel Gonzalez, et al.
HemaSphere (2024) Vol. 8, Iss. 9
Open Access
Jurrian K. de Kanter, Alexander S. Steemers, Daniel Montiel Gonzalez, et al.
HemaSphere (2024) Vol. 8, Iss. 9
Open Access
T-Cells Rich Classical Hodgkin Lymphoma, a Pathology Diagnostic Pitfall for Nodular Lymphocyte-Predominant Hodgkin Lymphoma; Case Series and Review
Haneen Al-Maghrabi, Ghadeer Mokhtar, Ahmed Noorsaeed
Lymphatics (2024) Vol. 2, Iss. 3, pp. 168-176
Open Access
Haneen Al-Maghrabi, Ghadeer Mokhtar, Ahmed Noorsaeed
Lymphatics (2024) Vol. 2, Iss. 3, pp. 168-176
Open Access
Identification of a core transcriptional program driving the human renal mesenchymal-to-epithelial transition
John-Poul Ng-Blichfeldt, Benjamin Stewart, Menna R. Clatworthy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
John-Poul Ng-Blichfeldt, Benjamin Stewart, Menna R. Clatworthy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1